Pignata, S., Oza, A. M., Hall, G., Pardo, B., Madry, R., Cibula, D., . . . Clamp, A. (2023). Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial.
Citação norma ChicagoPignata, Sandro, et al. Maintenance Olaparib in Patients With Platinum-sensitive Relapsed Ovarian Cancer: Outcomes By Somatic and Germline BRCA and Other Homologous Recombination Repair Gene Mutation Status in the ORZORA Trial. 2023.
Citação norma MLAPignata, Sandro, et al. Maintenance Olaparib in Patients With Platinum-sensitive Relapsed Ovarian Cancer: Outcomes By Somatic and Germline BRCA and Other Homologous Recombination Repair Gene Mutation Status in the ORZORA Trial. 2023.